Version July 2025
| Focal |
| Self-limited neonatal epilepsy (SeLNE) |
| Self-limited familial neonatal and infantile epilepsy (SeLFNIE) |
| Self-limited infantile epilepsy (SeLIE) |
| Focal and/or generalized |
| Genetic epilepsy with febrile seizures plus (GEFS+) |
| Generalized |
| Myoclonic epilepsy in infancy (MEI) |
| Developmental and epileptic encephalopathies (DEEs) |
| Early infantile DEE (EIDEE) |
| Epilepsy in infancy with migrating focal seizures (EIMFS) |
| Infantile epileptic spasms syndrome (IESS) |
| Dravet syndrome (DS) |
| Etiology-specific syndromes* |
| KCNQ2 DEE (KCNQ2-DEE) |
| Pyridoxine-dependent (ALDH7A1) DEE (PD-DEE) |
| Pyridoxamine 5'-phosphate deficiency (PNPO) DEE (P5PD-DEE) |
| CDKL5 DEE (CDKL5-DEE) |
| Protocadherin 19 clustering epilepsy (PCDH19 clustering epilepsy) |
| Glucose transporter 1 deficiency syndrome (GLUT1DS) |
| Sturge-Weber syndrome (SWS) |
| Gelastic seizures with hypothalamic hamartoma (GS-HH) |
